Skin-protection composition containing dendrobium-based ingredients

Patent metadata

Field	Value
Publication number	US-9956152-B2
Application number	US-201615352903-A
Country	US
Kind code	B2
Filing date	Nov 16, 2016
Priority date	Jun 16, 2015
Publication date	May 1, 2018
Grant date	May 1, 2018

Abstract

A skin-protection composition is shown that comprises stilbenoid(s) and/or stilbenoid-containing extract(s) obtained from Dendrobium plants, such as Dendrobium officinale and Dendrobium nobile for the management of melanogenesis, skin-darkening and skin-aging. More particularly, the usage of Dendrobium ingredients and stilbenoids is shown to reduce the formation of melanin in melanocytes. The usage of Dendrobium ingredients and stilbenoids is also shown to reduce the generation of reactive oxygen species and oxidative free radicals. The use of Dendrobium -derived extracts or ingredients or stilbenoids is shown in the formulation of skin-protection, skin-whitening and/or anti-skin aging products.

First claim

The invention claimed is:

1. A compound comprising formula (4):

wherein
R 2 , R 4 , and R 8 are each independently selected from —OR 11 , —OCH 2 R 12 , —OC(O)R 11 , —OCH 2 C(O)OR 12 and —OC(O)CH 2 R 12 ;
R 1 , R 3 , R 5 , R 6 , R 7 , R 9 and R 10 are each independently selected from hydrogen, halogen, trifluoromethyl, —OR 12 and —OC(O)R 12 ; or R 2 and R 3 , or R 7 and R 8 may be taken together with the carbon atoms to which they are attached to form a cyclic group;
R 11 is independently selected from —(CH 2 )-hydrocarbyl, C 2-10 alkyl, alkenyl, carbocyclyl, aryl and heteroaryl, wherein each of these groups is optionally substituted with 1, 2, 3, 4 or 5 R 13 ;
R 12 is independently selected from hydrocarbyl and heterocyclyl, either of which is optionally substituted with 1, 2, 3, 4 or 5 R 13 ;
R 13 is independently selected from halogen, trifluoromethyl, cyano, nitro, oxo, —OR 14 , —C(O)R 15 , —C(O)N(R 14 )R 15 , —C(O)OR 14 , —OC(O)R 15 , —S(O) 2 R 14 , —S(O) 2 N(R 14 )R 15 , —N(R 14 )R 15 ;
R 14 and R 15 are each independently hydrogen or selected from hydrocarbyl and heterocyclyl, either of which is optionally substituted with 1, 2, 3, 4 or 5 substituents independently selected from halogen, cyano, amino, hydroxy, C 1-6 alkyl and C 1-6 alkoxy
or a pharmaceutically acceptable salt, prodrug, derivative or chemical variant thereof.

2. A compound selected from DR1, DR2, DR3, DR4, DR5, DR6, DR7, DR8, DR9, DR10 or DR11 with the following formulae respectively:

or a pharmaceutically acceptable salt or prodrug thereof.

3. A pharmaceutical composition comprising the compound of claim 1 , wherein the pharmaceutical composition is in the form of a day cream, a night cream, a face lotion, a body lotion, a body butter, a skin peel, a mask, a shower gel, a sun cream, a sun lotion, an after sun cream or an after sun lotion.

Assignees

• Univ Hong Kong Baptist Univ

Inventors

• Zhang Hongjie
• Tsang Siu Wai
• Zhu Yu

Classifications

• A61P35/00

  Antineoplastic agents · CPC title

• C07C2601/08

  the ring being saturated · CPC title

• C07C69/34

  Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom · CPC title

• A61K31/09

  having two or more such linkages · CPC title

• A61K31/085

  having an ether linkage to aromatic ring nuclear carbon · CPC title